Mr. Speaker, an application for the BCG therapeutic product used in treating cancer of the bladder was filed by Connaught Laboratories on March 2, 1989. The notice of compliance was issued on April 25, 1990. The approval process thus took 13 1/2 months.
The Biochem file on BCG cancer, a product intended to treat bladder cancer, was received on June 10, 1992. The hon. member must realize that we receive a growing number of submissions of new research drugs and new drugs that qualify for priority evaluation; this increase is mainly due to progress in the biotechnology industry.
These priority applications take precedence over regular ones that are already being processed in order of receipt. Many physicians wishing to obtain the product from Biochem in order
to treat patients in their care can do so through the Emergency Drug Distribution Program.